Market Overview:
The global bioimpedance devices market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, and technological advancements in bioimpedance devices. Based on type, the global bioimpedance devices market is segmented into single-frequency bioimpedance devices and multiple-frequency bioimpedance devices. Based on application,theglobalbiomedical Devicesmarketis segmented into hospitals, clinics, rehabilitation centers, and others (including research institutes and home care settings). Hospitals account for the largest share of this market owing to their large patient population baseand growing demand for advanced medical treatments such as cancer treatmentand dialysis treatment .Geographically speaking ,theglobal biomedic al Devicesmarketis segmentedinto North America , Latin America Europe Asia Pacific Middle East & Africa .
Product Definition:
A bioimpedance device is a medical device that is used to measure the electrical properties of biological tissues. This information can be used to help diagnose various medical conditions.
Single-frequency Bioimpedance Devicess:
Single-frequency bioimpedance device is a novel diagnostic and monitoring tool that measures the body fluid volume status by noninvasive physical methods. It helps to diagnose several medical conditions including congestive heart failure, edema, liver or kidney disease, hypertension and renal dysfunction. The single frequency bioimpedance device works on different principle than other conventional devices such as multi-frequency or capacitive sensors do.
Multiple-frequency Bioimpedance Devicess:
Bioimpedance devices are used to measure the body's resistive power or capacitive reactance in terms of health. The device is an effective and non-invasive technique that measures the total body fluids, electrolytes, and proteins through skin (throughout) or blood samples.
Application Insights:
The others segment held the largest share of the global bioimpedance devices market in 2017. This is attributed to an increase in patients coming for treatment at non-clinical facilities, such as rehabilitation centers and hospitals. The growing geriatric population across the world is also expected to contribute significantly towards growth over the forecast period. As per WHO, by 2050 there will be more than 70 million people above 60 years of age globally, which in turn will boost demand for BIA devices during the forecast period.
The clinics segment is anticipated to grow at a significant rate over the forecast period owing to increasing awareness about health and wellness among consumers across various regions of the world including North America and Europe Pacific region.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing cases of obesity and diabetes, which require regular monitoring. In addition, rising awareness about personal health among people is one of the major factors driving regional growth.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to improving healthcare infrastructure and growing patient awareness levels regarding bioimpedance devices usage for early detection of various diseases. Moreover, government initiatives for creating new opportunities in this sector are expected to drive regional demand during the estimated time span. For instance, according with World Health Organization (WHO), by 2030 at least 50% of all hospitals will be required provide comprehensive primary healthcare services that include screening and diagnosis using advanced technologies such as bioimpedance devices in low-income countries with high unmet medical needs like India or China (WHO).
Growth Factors:
- Increasing prevalence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyles and dietary habits of people across the world. According to a study by the World Health Organization (WHO), chronic diseases are responsible for 63% of all deaths worldwide. This number is expected to increase in the coming years due to the rising incidence of obesity and diabetes mellitus. Bioimpedance devices can be used to monitor these conditions and help manage them effectively.
- Growing demand for personalized medicine: There has been a growing demand for personalized medicine in recent years, as patients want treatments that are tailored specifically for them. Bioimpedance devices can be used to measure various physiological parameters such as body composition, muscle mass, hydration levels, etc., which can help doctors prescribe customized treatment plans for their patients.
- Advances in technology: The field of bioimpedance measurement has seen rapid advances in technology over the past few years, thanks to advancements in microelectronics and data analytics algorithms. This has led to more accurate and reliable bioimpedance measurements, which is helping fuel growth in this market segment .
Scope Of The Report
Report Attributes
Report Details
Report Title
Bioimpedance Devices Market Research Report
By Type
Single-frequency Bioimpedance Devicess, Multiple-frequency Bioimpedance Devicess
By Application
Hospitals, Clinics, Rehabilitation Centers, Others
By Companies
General Electric, Omron, Fresenius Medical Care, RJL Systems, ImpediMed, Bodystat, Selvas AI, Tanita, SMT Medical, Cerebrotech Medical Systems, Maltron International
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Bioimpedance Devices Market Report Segments:
The global Bioimpedance Devices market is segmented on the basis of:
Types
Single-frequency Bioimpedance Devicess, Multiple-frequency Bioimpedance Devicess
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Rehabilitation Centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- General Electric
- Omron
- Fresenius Medical Care
- RJL Systems
- ImpediMed
- Bodystat
- Selvas AI
- Tanita
- SMT Medical
- Cerebrotech Medical Systems
- Maltron International
Highlights of The Bioimpedance Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Single-frequency Bioimpedance Devicess
- Multiple-frequency Bioimpedance Devicess
- By Application:
- Hospitals
- Clinics
- Rehabilitation Centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bioimpedance Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bioimpedance devices (BID) are medical devices that measure electrical resistance in body tissues. The electrical resistance is used to diagnose and monitor the health of the tissue.
Some of the key players operating in the bioimpedance devices market are General Electric, Omron, Fresenius Medical Care, RJL Systems, ImpediMed, Bodystat, Selvas AI, Tanita, SMT Medical, Cerebrotech Medical Systems, Maltron International.
The bioimpedance devices market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Bioimpedance Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Bioimpedance Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Bioimpedance Devices Market - Supply Chain
4.5. Global Bioimpedance Devices Market Forecast
4.5.1. Bioimpedance Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Bioimpedance Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Bioimpedance Devices Market Absolute $ Opportunity
5. Global Bioimpedance Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Bioimpedance Devices Market Size and Volume Forecast by Type
5.3.1. Single-frequency Bioimpedance Devicess
5.3.2. Multiple-frequency Bioimpedance Devicess
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Bioimpedance Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Bioimpedance Devices Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Rehabilitation Centers
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Bioimpedance Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Bioimpedance Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Bioimpedance Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Bioimpedance Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Bioimpedance Devices Demand Share Forecast, 2019-2026
9. North America Bioimpedance Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Bioimpedance Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Bioimpedance Devices Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Rehabilitation Centers
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Bioimpedance Devices Market Size and Volume Forecast by Type
9.7.1. Single-frequency Bioimpedance Devicess
9.7.2. Multiple-frequency Bioimpedance Devicess
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Bioimpedance Devices Demand Share Forecast, 2019-2026
10. Latin America Bioimpedance Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Bioimpedance Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Bioimpedance Devices Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Rehabilitation Centers
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Bioimpedance Devices Market Size and Volume Forecast by Type
10.7.1. Single-frequency Bioimpedance Devicess
10.7.2. Multiple-frequency Bioimpedance Devicess
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Bioimpedance Devices Demand Share Forecast, 2019-2026
11. Europe Bioimpedance Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Bioimpedance Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Bioimpedance Devices Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Rehabilitation Centers
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Bioimpedance Devices Market Size and Volume Forecast by Type
11.7.1. Single-frequency Bioimpedance Devicess
11.7.2. Multiple-frequency Bioimpedance Devicess
11.8. Basis Point Share (BPS) Analsis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Bioimpedance Devices Demand Share, 2019-2026
12. Asia Pacific Bioimpedance Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Bioimpedance Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Bioimpedance Devices Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Rehabilitation Centers
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Bioimpedance Devices Market Size and Volume Forecast by Type
12.7.1. Single-frequency Bioimpedance Devicess
12.7.2. Multiple-frequency Bioimpedance Devicess
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Bioimpedance Devices Demand Share, 2019-2026
13. Middle East & Africa Bioimpedance Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Bioimpedance Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Bioimpedance Devices Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Rehabilitation Centers
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Bioimpedance Devices Market Size and Volume Forecast by Type
13.7.1. Single-frequency Bioimpedance Devicess
13.7.2. Multiple-frequency Bioimpedance Devicess
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Bioimpedance Devices Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Bioimpedance Devices Market: Market Share Analysis
14.2. Bioimpedance Devices Distributors and Customers
14.3. Bioimpedance Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. General Electric
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Omron
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Fresenius Medical Care
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. RJL Systems
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. ImpediMed
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Bodystat
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Selvas AI
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Tanita
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. SMT Medical
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Cerebrotech Medical Systems
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Maltron International
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook